These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1970770)
1. The metabolism and disposition of 14C-fenofibrate in human volunteers. Weil A; Caldwell J; Strolin-Benedetti M Drug Metab Dispos; 1990; 18(1):115-20. PubMed ID: 1970770 [TBL] [Abstract][Full Text] [Related]
2. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog. Weil A; Caldwell J; Strolin-Benedetti M Drug Metab Dispos; 1988; 16(2):302-9. PubMed ID: 2898351 [TBL] [Abstract][Full Text] [Related]
3. [Metabolism of fenofibrate and fenofibric acid in vivo and in cultures of liver epithelial cells (author's transl)]. Dulery B; Hammami M; Chessebeuf M; Legendre M; Noly P; Padieu P; Maume BF Nouv Presse Med; 1980 Dec; 9(49):3729-32. PubMed ID: 7208338 [TBL] [Abstract][Full Text] [Related]
4. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Emudianughe TS; Caldwell J; Sinclair KA; Smith RL Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
6. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects. Gustavson LE; Schweitzer SM; Burt DA; Achari R; Rieser MJ; Edeki T; Chira T; Yannicelli HD; Kelly MT Clin Ther; 2006 Mar; 28(3):373-87. PubMed ID: 16750452 [TBL] [Abstract][Full Text] [Related]
8. Species differences in the chirality of the carbonyl reduction of [14C] fenofibrate in laboratory animals and humans. Weil A; Caldwell J; Guichard JP; Picot G Chirality; 1989; 1(3):197-201. PubMed ID: 2642049 [TBL] [Abstract][Full Text] [Related]
9. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat. Bolton GC; Griffiths LA Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
11. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Grislain L; Gele P; Bertrand M; Luijten W; Bromet N; Salvadori C; Kamoun A Drug Metab Dispos; 1990; 18(5):804-8. PubMed ID: 1981739 [TBL] [Abstract][Full Text] [Related]
12. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans. Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375 [TBL] [Abstract][Full Text] [Related]
15. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869 [TBL] [Abstract][Full Text] [Related]
16. The metabolic disposition of [methoxy-14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers. Sangster SA; Caldwell J; Hutt AJ; Anthony A; Smith RL Xenobiotica; 1987 Oct; 17(10):1223-32. PubMed ID: 3424869 [TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
18. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic? Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of clarithromycin in man. Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065 [TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of 14C-rifapentine in healthy volunteers. Reith K; Keung A; Toren PC; Cheng L; Eller MG; Weir SJ Drug Metab Dispos; 1998 Aug; 26(8):732-8. PubMed ID: 9698286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]